维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="NAKAIGAWA N"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Composite distal nephron-derived renal cell carcinoma with chromophobe and collecting duct carcinomatous elements显示文摘	Inayama Y Nakaigawa N	2005	Pathol Int2005，55，6：	1
2	Free PSA/total PSA ralio increases the detection rate of prostate cancer in twelve-core biopsy 显示文摘	Yokomizo Y Miyoshi Y Nakaigawa N	2009	Urologia Internationalis2009，82，3：	1
3	Receptor for advanced glycation end products and its ligand, amphoterin are overexpressed and associat- ed with prostate cancer developmen显示文摘	ISHIGURO H NAKAIGAWA N MIYOSHI Y	2005	Prostate2005，64，：	1
4	Angiotensin Ⅱ blocker decreases serum prostate specific antigen in hormone refractory prostate cancer显示文摘	Yamagishit Uemura H Nakaigawa N	2005	J Urol2005，173，2：	1
5	Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer显示文摘	Uemura H Nakaigawa N Ishiguro H	2005	Current Cancer Drug Targets2005，5，5：	1
6	Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells:a possibility of tyrosine kinase inhibitor of growth factor显示文摘	Uemura H Ishiguro H Nakaigawa N		0，，：	1
7	Angiotensin Ⅱ blocker decreases serum prostate specific antigen in hormone refi'actory prostste cancer显示文摘	Yamagish T Uemura H Nakaigawa N	2005	J Urol2005，173，2：	1
8	Inactivation of yon HippelLindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma显示文摘	Nakaigawa N Yao M Baba M	2006	Cancer Res2006，66，：	1
9	Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development 显示文摘	Ishiguro H Nakaigawa N Miyoshi Y	2005	Prostate2005，64，1：	1
10	Receptor for advanced glycation end products (RAGE) and its ligand,amphoterin are overexpressed and associated with prostate cancer development显示文摘	Ishiguro H Nakaigawa N Miyoshi Y	2005	Prostate2005，64，1：	1
11	Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells:a possibility of tyrosine kinase inhibitor of growth factor显示文摘	Uemura H Ishiguro H Nakaigawa N	2003	Mol Cancer Ther2003，2，11：	1
12	Chromophobe renal cell carcinoma:a clinicopathological study of 16 cases显示文摘	Nakaigawa N Yao M Kondo K	2006	Hinyokika Kiyo2006，52，：	1
13	Receptor for advanced glycation end products(RAGE)and its ligand,amphoterin are overexpressed and associated with prostate cancer development显示文摘	Ishiguro H Nakaigawa N Miyoshi Y	2005	Prostate2005，64，1：	1
14	Receptor for advanced glycation end products (RAGE)and its ligand, amphotefin are overexpressed and associated with prostate cancer development 显示文摘	Ishiguro H Nakaigawa N Miyoshi Y	2005	Prostate2005，64，1：	1
15	Receptor for advanced glycation end products(RAGE) and its ligand, amphoterin are overexpressed and associatod with prostate cancer development 显示文摘	Ishiguro H Nakaigawa N Miyoshi Y	2005	Prostate2005，64，1：	1
16	Chromophobe renal cell carcinoma:a clinicopathological study of 16 cases显示文摘	Nakaigawa N Yao M Kondo K	2006	Hinyokika Kiyo2006，52，1：	1
17	Receptor for advanced glycation end products (RAGE) and its ligand,amphoterin are over expressed and associated with prostate cancer development显示文摘	Ishiguro H Nakaigawa N Miyoshi Y	2005	Prostate2005，64，1：	1
18	Novel mutations of the MET proto-oncogene in papillary renal carcino- mas显示文摘	SCHMIDT L JUNKER K NAKAIGAWA N	1999	Oncogene1999，18，14：	1
19	Activating mutations for the met tyrosine kinase receptor in human cancer显示文摘	Jeffers M Schmidt L Nakaigawa N	1997	Proc Natl Acad Sci USA1997，94，11：	1
20	Activating mutations for the met tyrosine kinase receptor in human cancer显示文摘	Jeffers M Schmidt L Nakaigawa N	1997	Proc Natl Acad Sci USA1997，94，11：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示